The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities

Eitemau Tebyg

• Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model
  gan: Arora, A, et al.
  Cyhoeddwyd: (2022)
• The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
  gan: Chiara Suvieri, et al.
  Cyhoeddwyd: (2024-11-01)
• Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
  gan: Quan, J, et al.
  Cyhoeddwyd: (2008)
• Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
  gan: Quan, J, et al.
  Cyhoeddwyd: (2008)
• TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
  gan: V. A. Kozlov, et al.
  Cyhoeddwyd: (2017-07-01)